All lobbying filings

SUMMIT HEALTH CARE CONSULTING

SUMMIT HEALTH CARE CONSULTING filed a Q2 report for NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION on July 21, 2026, reporting $25,500 in lobbying income.

Lobbying for NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · Health care trade association

All filings by SUMMIT HEALTH CARE CONSULTING · Everything NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 21, 2026

Income

$25,500

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 1

CAMILLE BONTA

Previously held: Legislative Correspondent, U.S. Senator John Glenn

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.

Medicare/Medicaid

Support the Ensuring Medicare and Medicaid Beneficiaries Access to Timely Care Act of 2026 which requires prior authorization reform and applies to Part D, CHIP, Medicaid. No bill introduced in 2nd quarter

Bills named in this filing 3

H.R. 5684
Medical Foods and Formulas Access Act of 2025
S. 3304
Medical Foods and Formulas Access Act of 2025
H.R. 9192
Prior Authorization Reform for Autoimmune and Blood Disorders Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.